Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

Cited In for PubMed (Select 17605302)

1.

Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance.

Srivastava SK, Arora S, Averett C, Singh S, Singh AP.

Biomed Res Int. 2015;2015:848710. doi: 10.1155/2015/848710. Epub 2015 Mar 17. Review.

2.

Multiple therapeutic and preventive effects of 3,3'-diindolylmethane on cancers including prostate cancer and high grade prostatic intraepithelial neoplasia.

Zhang WW, Feng Z, Narod SA.

J Biomed Res. 2014 Sep;28(5):339-48. doi: 10.7555/JBR.28.20140008. Epub 2014 Apr 20.

3.

Chemoprevention in gastrointestinal physiology and disease. Natural products and microbiome.

Greiner AK, Papineni RV, Umar S.

Am J Physiol Gastrointest Liver Physiol. 2014 Jul 1;307(1):G1-15. doi: 10.1152/ajpgi.00044.2014. Epub 2014 May 1. Review.

4.

Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention.

Kumar N, Chornokur G.

Transl Med (Sunnyvale). 2012 Dec 31;Suppl 2:005.

5.

Comparative preclinical pharmacokinetics study of 3,3'-diindolylmethane formulations: is personalized treatment and targeted chemoprevention in the horizon?

Paltsev M, Kiselev V, Muyzhnek E, Drukh V, Kuznetsov I, Pchelintseva O.

EPMA J. 2013 Dec 10;4(1):25. doi: 10.1186/1878-5085-4-25.

6.

The safety of cruciferous plants in humans: a systematic review.

Scott O, Galicia-Connolly E, Adams D, Surette S, Vohra S, Yager JY.

J Biomed Biotechnol. 2012;2012:503241. doi: 10.1155/2012/503241. Epub 2012 Feb 22. Review.

7.

MicroRNA, nutrition, and cancer prevention.

Ross SA, Davis CD.

Adv Nutr. 2011 Nov;2(6):472-85. doi: 10.3945/an.111.001206. Epub 2011 Nov 3. Review.

8.

Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatory effects on murine dendritic cells.

Benson JM, Shepherd DM.

Toxicol Sci. 2011 Dec;124(2):327-38. doi: 10.1093/toxsci/kfr249. Epub 2011 Sep 26.

9.

Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.

Navarro SL, Li F, Lampe JW.

Food Funct. 2011 Oct;2(10):579-87. doi: 10.1039/c1fo10114e. Epub 2011 Sep 21. Review.

10.

Indole-3-carbinol inhibited tobacco smoke carcinogen-induced lung adenocarcinoma in A/J mice when administered during the post-initiation or progression phase of lung tumorigenesis.

Qian X, Melkamu T, Upadhyaya P, Kassie F.

Cancer Lett. 2011 Dec 1;311(1):57-65. doi: 10.1016/j.canlet.2011.06.023. Epub 2011 Jul 2.

11.

Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates.

Saw CL, CintrĂ³n M, Wu TY, Guo Y, Huang Y, Jeong WS, Kong AN.

Biopharm Drug Dispos. 2011 Jul;32(5):289-300. doi: 10.1002/bdd.759. Epub 2011 Jun 8.

12.

The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines.

De Santi M, Galluzzi L, Lucarini S, Paoletti MF, Fraternale A, Duranti A, De Marco C, Fanelli M, Zaffaroni N, Brandi G, Magnani M.

Breast Cancer Res. 2011 Mar 24;13(2):R33. doi: 10.1186/bcr2855.

13.

Modulating human aging and age-associated diseases.

Fontana L.

Biochim Biophys Acta. 2009 Oct;1790(10):1133-8. doi: 10.1016/j.bbagen.2009.02.002. Epub 2009 Feb 10. Review.

14.

Indole-3-carbinol as a chemopreventive and anti-cancer agent.

Weng JR, Tsai CH, Kulp SK, Chen CS.

Cancer Lett. 2008 Apr 18;262(2):153-63. doi: 10.1016/j.canlet.2008.01.033. Epub 2008 Mar 7. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk